Related references
Note: Only part of the references are listed.Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal mild-155 in a rat model of diabetic neuropathy
Ghada M. El-Lithy et al.
TRANSLATIONAL RESEARCH (2016)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?
Nadine Attal et al.
PAIN (2015)
Agmatine: clinical applications after 100 years in translation
John E. Piletz et al.
DRUG DISCOVERY TODAY (2013)
Reduced conduction failure of the main axon of polymodal nociceptive C-fibres contributes to painful diabetic neuropathy in rats
Wei Sun et al.
BRAIN (2012)
Phosphorylation of spinal N-methyl-D-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy
Laurence Daulhac et al.
EUROPEAN JOURNAL OF PAIN (2011)
Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia
Mohamed Reda Halawa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Regulation of nitric oxide production in health and disease
Yvette C. Luiking et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain
L. J. Rondon et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Arginine metabolism and nutrition in growth, health and disease
Guoyao Wu et al.
AMINO ACIDS (2009)
Novel Therapies for the Control and Prevention of Neuropathic Pain
Christine N. Sang et al.
NEUROTHERAPEUTICS (2009)
Pathophysiology and treatment of painful diabetic neuropathy
Mitra Tavakoli et al.
CURRENT PAIN AND HEADACHE REPORTS (2008)
A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain Conditions
Alesia Sadosky et al.
Pain Practice (2008)
Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist
Christine Courteix et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France
E. Q. Wu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Diabetic neuropathy - a review
Gerard Said
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance
WY Chien et al.
DIABETES & METABOLISM (2005)
Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine
SAV Raghavan et al.
PHARMACOLOGICAL RESEARCH (2004)
Dossier: Free amino acids in human health and pathologies - The metabolic basis of arginine nutrition and pharmacotherapy
NE Flynn et al.
BIOMEDICINE & PHARMACOTHERAPY (2002)
Effects of diabetes mellitus and acute hypertension on plasma nitric oxide and endothelin concentrations in rats
P Vural et al.
CLINICA CHIMICA ACTA (2002)
Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients
P Piatti et al.
DIABETES CARE (2001)
The clinical pharmacology of L-arginine
RH Boger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury
CA Fairbanks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)